article thumbnail

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

Health Populi

When I talk about patient support programs (PSPs), I’m most often focused on supporting peoples’ access to medicines due to costs, bolstering health literacy, and addressing health citizens’ risks of drivers of health that can be obstacles to optimal health outcomes (those challenging social determinants of health).

article thumbnail

The Evolution of a Patient Ambassador – Learning from Stacy Hurt

Health Populi

Fast-forward to her diagnosis in 2014 with Stage IV colorectal cancer, when Stacy emerged as an expert advocate due to her previous personal and professional experience.

article thumbnail

In Search of Clinical Effectiveness, But “Investment Exuberance?” Not So Much. Insights From FINN Partners and Galen Growth at HLTH 2022

Health Populi

In a clinical excellence framework with more rationalized exuberance, the new-new digital health things should be underpinned by clinical evidence and excellence and — if they are very, very good things — they will address the Quintuple Aim by, Enhancing the care experience. Reducing costs per capita (per patient).

article thumbnail

Building Trust and Truth in Patient Social Networks

Health Populi

Social networks give providers-at-risk the opportunity to scale care to larger patient populations, identifying disease-specific patient support groups and caregiver support groups as very powerful platforms for that scaling.

article thumbnail

What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

Health Populi

I’ll maintain for the planning process over the coming 1-5 years that the prescription drug line item in American households will “feel” like a retail expense depending on the family’s health issues and economic confidence in their personal and community economies.